News | March 15, 2023
LifeSigns raises Pre-Series A
A funding to expand operations and provide better patient care
A funding to expand operations and provide better patient care
Chronic Kidney Disease is a growing epidemic with 850 million people affected worldwide.
First approval for Daiichi Sankyo and AstraZeneca’s ENHERTU in China
Merck and Ridgeback will appeal the decision and request a re-examination of the CHMP’s opinion.
The new Beyfortus data are consistent with all data accumulated to date and confirm its strong profile
This artificial RNA ligase has higher thermostability than natural RNA ligase
The safety profile of LAGEVRIO in this trial was generally consistent with that observed in previously reported clinical studies
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
IAGES to focus on upskilling and adoption of advanced Minimal Access Surgery technologies in 2023
The partnership is announced at Aero India 2023, Bangalore
Subscribe To Our Newsletter & Stay Updated
